PERTUZUMAB [420 MG/14 ML; SOL INJ; FRS] PERTUZUMAB [420 MG/14 ML; SOL INJ; FRS]
Antineoplastické a imunomodulačné činidlá pre potreby FNsP. Antineoplastické a imunomodulačné činidlá pre potreby FNsP.
IMUNOGLOBULINA ANTILINFÓCITOS (COELHO) [25 MG; PÓ P/ CONC P/A SOL P/ PERF; FRS] IMUNOGLOBULINA ANTILINFÓCITOS (COELHO) [25 MG; PÓ P/ CONC P/A SOL P/ PERF; FRS]
DAROLUTAMIDA [300 MG; CÁP/COMP] DAROLUTAMIDA [300 MG; CÁP/COMP]
BELIMUMAB [200 MG/1ML; SOL INJ; CANETA] BELIMUMAB [200 MG/1ML; SOL INJ; CANETA]
IMUNOGLOBULINA ANTILINFÓCITOS (COELHO) [25 MG; PÓ P/ CONC P/A SOL P/ PERF; FRS] IMUNOGLOBULINA ANTILINFÓCITOS (COELHO) [25 MG; PÓ P/ CONC P/A SOL P/ PERF; FRS]
IBRUTINIB [140 MG; CÁP/COMP] IBRUTINIB [140 MG; CÁP/COMP]
DAROLUTAMIDA [300 MG; CÁP/COMP] DAROLUTAMIDA [300 MG; CÁP/COMP]
LEUPRORRELINA [45 MG; PÓ E SOLV P/ SOL INJ; SERINGA] LEUPRORRELINA [45 MG; PÓ E SOLV P/ SOL INJ; SERINGA]
PERTUZUMAB [420 MG/14 ML; SOL INJ; FRS] PERTUZUMAB [420 MG/14 ML; SOL INJ; FRS]